We're desperate for a coronavirus cure, but at what cost to the human guinea pigs? | Kenan Malik

Big drugs companies have long favoured outsourcing clinical trials to poor countries with lax regulations to cut costs and maximise profit• Coronavirus latest updates• See all our coronavirus coverageLast week, in Oxford, the first volunteers in the first European human trial were injected with a potentialcoronavirus vaccine. At the same time, Pakistan ’s National Institute of Healthreceived an offer from the Chinese pharmaceutical firm Sinopharm International Corp to take part in a trial of another potential coronavirus vaccine.Related:Africa's Covid-19 research must be tailored to its realities – by its own scientists | Monique WasunnaContinue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak Medical research Pharmaceuticals industry Infectious diseases Aids and HIV Microbiology Business Science World news Source Type: news